Home/Filings/4/0001567619-19-023147
4//SEC Filing

Mobasher Mehrdad 4

Accession 0001567619-19-023147

CIK 0001626971other

Filed

Dec 15, 7:00 PM ET

Accepted

Dec 16, 4:15 PM ET

Size

5.5 KB

Accession

0001567619-19-023147

Insider Transaction Report

Form 4
Period: 2019-12-12
Mobasher Mehrdad
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2019-12-12+50,00050,000 total
    Exercise: $3.54Exp: 2029-12-12Common Stock (50,000 underlying)
Footnotes (1)
  • [F1]The underlying shares subject to the option vest and become exercisable as to one-forty eighth (1/48th) of the shares subject to the option in successive, equal monthly installments measured from December 12, 2019, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

Documents

1 file

Issuer

Corvus Pharmaceuticals, Inc.

CIK 0001626971

Entity typeother

Related Parties

1
  • filerCIK 0001765484

Filing Metadata

Form type
4
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 4:15 PM ET
Size
5.5 KB